I believe that along with Merck and Catalent we will have a couple of prescription meds selling worldwide. Here in the US we will have research contracts with the DEA (do not underestimate this), distribution, genetics, NDC (nobody knows under which of our 10+ partners and subs it will be under), grow supply (seed to sale),International marketing, FDA approval, Europe and international presence via Euromed which puts us several years ahead of ALL of our competition. We are on the precipice my friends. This is all 100% part of our plan.NOT an opinion!
#MJCONGLOMERATE